Recent Price Movement and Market Context
Thyrocare’s stock has been on a downward trajectory over the past week, losing 17.43% in value while the Sensex remained virtually flat with a marginal 0.01% gain. This marks a significant divergence from the benchmark, highlighting a phase of profit-taking or correction after a period of strong appreciation. Over the last month, the stock also declined by 8.73%, contrasting with the Sensex’s 2.70% rise. Despite these short-term setbacks, the stock has delivered a robust 35.79% return year-to-date and outperformed the Sensex by a wide margin over one, three, and five-year horizons.
On 05-Dec, the stock touched an intraday low of ₹408.10, reflecting selling pressure as more volume traded near the day’s low price. The weighted ave...
Read More










